Cargando…

Survival benefit of a low ratio of visceral to subcutaneous adipose tissue depends on LDL clearance versus production in sepsis

BACKGROUND: Patients with sepsis with a high ratio of visceral adipose tissue (VAT) to subcutaneous adipose tissue (SAT) have increased mortality. Our goal was to investigate the mechanism of this effect, noting that low LDL levels are also associated with increased sepsis mortality. Accordingly we...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Joseph G. H., Genga, Kelly R., Pisitsak, Chawika, Boyd, John H., Leung, Alex K. K., Russell, James A., Walley, Keith R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840798/
https://www.ncbi.nlm.nih.gov/pubmed/29510719
http://dx.doi.org/10.1186/s13054-018-1985-1
_version_ 1783304646040748032
author Lee, Joseph G. H.
Genga, Kelly R.
Pisitsak, Chawika
Boyd, John H.
Leung, Alex K. K.
Russell, James A.
Walley, Keith R.
author_facet Lee, Joseph G. H.
Genga, Kelly R.
Pisitsak, Chawika
Boyd, John H.
Leung, Alex K. K.
Russell, James A.
Walley, Keith R.
author_sort Lee, Joseph G. H.
collection PubMed
description BACKGROUND: Patients with sepsis with a high ratio of visceral adipose tissue (VAT) to subcutaneous adipose tissue (SAT) have increased mortality. Our goal was to investigate the mechanism of this effect, noting that low LDL levels are also associated with increased sepsis mortality. Accordingly we tested for association between VAT/SAT, low-density lipoprotein (LDL) levels, and mortality. Then we examined the effect of statin treatment, which decreases LDL production, and the effect of PCSK9 genotype, which increases LDL clearance. METHODS: We performed retrospective analysis of a cohort of patients with sepsis from a tertiary care adult intensive care unit in Vancouver, Canada, who underwent abdominal computed tomography (CT) (n = 75) for clinical reasons. We compared LDL levels in patients with sepsis according to high versus low VAT/SAT and 90-day survival. We next examined the effects of statin therapy and PCSK9 loss-of-function genotype on survival. RESULTS: Patients with a low VAT/SAT had increased 90-day survival and were relatively protected against low LDL levels in sepsis compared to high VAT/SAT. Statin treatment abrogated the beneficial effects of low VAT/SAT; eliminating the difference in LDL levels and survival between patients with low and high VAT/SAT. PSCK9 loss-of-function genotype similarly eliminated the increased LDL levels in low VAT/SAT patients but, in contrast, increased the survival advantage of low VAT/SAT compared to high VAT/SAT. CONCLUSIONS: Low LDL levels per se are not simply associated with decreased sepsis survival because lowering LDL levels by inhibiting LDL production (statin treatment) is associated with adverse outcomes, while increased LDL clearance (PCSK9 loss-of-function genotype) is associated with improved outcomes in patients with low VAT/SAT. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13054-018-1985-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5840798
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58407982018-03-14 Survival benefit of a low ratio of visceral to subcutaneous adipose tissue depends on LDL clearance versus production in sepsis Lee, Joseph G. H. Genga, Kelly R. Pisitsak, Chawika Boyd, John H. Leung, Alex K. K. Russell, James A. Walley, Keith R. Crit Care Research BACKGROUND: Patients with sepsis with a high ratio of visceral adipose tissue (VAT) to subcutaneous adipose tissue (SAT) have increased mortality. Our goal was to investigate the mechanism of this effect, noting that low LDL levels are also associated with increased sepsis mortality. Accordingly we tested for association between VAT/SAT, low-density lipoprotein (LDL) levels, and mortality. Then we examined the effect of statin treatment, which decreases LDL production, and the effect of PCSK9 genotype, which increases LDL clearance. METHODS: We performed retrospective analysis of a cohort of patients with sepsis from a tertiary care adult intensive care unit in Vancouver, Canada, who underwent abdominal computed tomography (CT) (n = 75) for clinical reasons. We compared LDL levels in patients with sepsis according to high versus low VAT/SAT and 90-day survival. We next examined the effects of statin therapy and PCSK9 loss-of-function genotype on survival. RESULTS: Patients with a low VAT/SAT had increased 90-day survival and were relatively protected against low LDL levels in sepsis compared to high VAT/SAT. Statin treatment abrogated the beneficial effects of low VAT/SAT; eliminating the difference in LDL levels and survival between patients with low and high VAT/SAT. PSCK9 loss-of-function genotype similarly eliminated the increased LDL levels in low VAT/SAT patients but, in contrast, increased the survival advantage of low VAT/SAT compared to high VAT/SAT. CONCLUSIONS: Low LDL levels per se are not simply associated with decreased sepsis survival because lowering LDL levels by inhibiting LDL production (statin treatment) is associated with adverse outcomes, while increased LDL clearance (PCSK9 loss-of-function genotype) is associated with improved outcomes in patients with low VAT/SAT. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13054-018-1985-1) contains supplementary material, which is available to authorized users. BioMed Central 2018-03-06 /pmc/articles/PMC5840798/ /pubmed/29510719 http://dx.doi.org/10.1186/s13054-018-1985-1 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Lee, Joseph G. H.
Genga, Kelly R.
Pisitsak, Chawika
Boyd, John H.
Leung, Alex K. K.
Russell, James A.
Walley, Keith R.
Survival benefit of a low ratio of visceral to subcutaneous adipose tissue depends on LDL clearance versus production in sepsis
title Survival benefit of a low ratio of visceral to subcutaneous adipose tissue depends on LDL clearance versus production in sepsis
title_full Survival benefit of a low ratio of visceral to subcutaneous adipose tissue depends on LDL clearance versus production in sepsis
title_fullStr Survival benefit of a low ratio of visceral to subcutaneous adipose tissue depends on LDL clearance versus production in sepsis
title_full_unstemmed Survival benefit of a low ratio of visceral to subcutaneous adipose tissue depends on LDL clearance versus production in sepsis
title_short Survival benefit of a low ratio of visceral to subcutaneous adipose tissue depends on LDL clearance versus production in sepsis
title_sort survival benefit of a low ratio of visceral to subcutaneous adipose tissue depends on ldl clearance versus production in sepsis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840798/
https://www.ncbi.nlm.nih.gov/pubmed/29510719
http://dx.doi.org/10.1186/s13054-018-1985-1
work_keys_str_mv AT leejosephgh survivalbenefitofalowratioofvisceraltosubcutaneousadiposetissuedependsonldlclearanceversusproductioninsepsis
AT gengakellyr survivalbenefitofalowratioofvisceraltosubcutaneousadiposetissuedependsonldlclearanceversusproductioninsepsis
AT pisitsakchawika survivalbenefitofalowratioofvisceraltosubcutaneousadiposetissuedependsonldlclearanceversusproductioninsepsis
AT boydjohnh survivalbenefitofalowratioofvisceraltosubcutaneousadiposetissuedependsonldlclearanceversusproductioninsepsis
AT leungalexkk survivalbenefitofalowratioofvisceraltosubcutaneousadiposetissuedependsonldlclearanceversusproductioninsepsis
AT russelljamesa survivalbenefitofalowratioofvisceraltosubcutaneousadiposetissuedependsonldlclearanceversusproductioninsepsis
AT walleykeithr survivalbenefitofalowratioofvisceraltosubcutaneousadiposetissuedependsonldlclearanceversusproductioninsepsis